Head of RWE Solutions and Senior Director, Science - EMEA
Aetion, Inc., Germany
With over 15 years of experience in epidemiology and biostatistics, I specialize in generating real-world evidence through pharmacoepidemiologic and statistical research using real-world data. I have a proven track record of developing studies end-to-end and identifying operational inefficiencies in research practices, along with corresponding business solutions. I am data fluent, working with a majority of commercially available electronic health record and administrative claims databases, European registries including those in rare diseases, as well as clinical trial, synthetic data, and privacy-preserving record linked datasets. I have a strong focus on clinical development and have a history of assisting large and medium-sized biopharmaceutical organizations to leverage RWE using best practices from epidemiology, biostatistics, and data science to make informed decisions for global impact. Currently, I lead teams at Aetion to conduct integrated evidence generation planning and regulatory-focused RWE study delivery as well as support our commercial teams to identify the right business solutions we offer to our customers from a scientific perspective.